Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma

Table 2 Tumor Response, RECIST (N = 115)

Clinical feature	N (%)	Survival Rate		p
Clinical feature	N (%)	1-yr (%)	2-yrs (%)	p
Complete Response	56 (48.7)	87.5	68.57
Partial Response	46 (40)	39.13	12.5
Stable	10 (8.7)	70	50
Tumor progression	3 (2.61)	0	0	0.001

ISSN: 1471-2407